GlaxoSmithKline: all 4,196 studies
Page 34 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular CarcinomaCompletedNCT00712855Phase 1
- Bioequivalence Study of Aciclovir 5% Cream in Japanese Healthy VolunteersCompletedNCT00711776Phase 1
- GSK706769 Repeat Dose StudyCompletedNCT00711386Phase 1
- A Study To Investigate Safety, Blood Levels And Effects Of Giving GW642444, By Mouth, By Inhalation & By InjectionCompletedNCT00711126Phase 1
- A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid TumorsCompletedNCT00708006Phase 1
- Evaluation of Pneumococcal Vaccine Formulations in Young AdultsCompletedNCT00707798Phase 1
- The Expression of Antigens in Bone Marrow Samples From Volunteering Donors.CompletedNCT00706199
- A Study With Darapladib to Collect Tolerability InformationCompletedNCT00704431Phase 1
- A First Time in Human Study of GSK586529 in Healthy VolunteersCompletedNCT00703547Phase 1
- A Study to Investigate the Effect of Inhaling Single Doses of Different Formulations of GW642444M in Asthmatic PatientsCompletedNCT00702910Phase 1
- Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes DiseaseCompletedNCT00699764Phase 3
- Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis PatientsCompletedNCT00699231Phase 1
- Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 yCompletedNCT00698906Phase 2
- Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive AdultsCompletedNCT00698893Phase 1
- Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative SubjectsCompletedNCT00698568Phase 3
- Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 yCompletedNCT00698555Phase 2
- Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell LinesCompletedNCT00698490Phase 1/2
- Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-BCompletedNCT00698087Phase 3
- Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15yCompletedNCT00698061Phase 3
- Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B VaccineCompletedNCT00697970Phase 3
- Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-RespondersCompletedNCT00697931Phase 3
- Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as ControlCompletedNCT00697866Phase 3
- Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy AdultsCompletedNCT00697853Phase 2
- Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-BCompletedNCT00697840Phase 3
- Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy AdolescentsCompletedNCT00697775Phase 2
- Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 GenotypeCompletedNCT00697749Phase 3
- Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without AdjuvantCompletedNCT00697567Phase 2
- Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of AgeCompletedNCT00697554Phase 3
- Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older AdultsCompletedNCT00697242Phase 3
- Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different SchedulesCompletedNCT00697229Phase 2
- Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).CompletedNCT00697216Phase 3
- Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different AdjuvantsCompletedNCT00697125Phase 2
- Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15yCompletedNCT00696917Phase 3
- Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in AdultsCompletedNCT00696891Phase 3
- Phase I Open-Label, Dose-Escalation Study of GSK1059615 in Patients With Solid Tumors or LymphomaTerminatedNCT00695448Phase 1
- An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 WeeksCompletedNCT00695305Phase 2
- Study to Assess Blood Levels of Itraconazole During a Two-Week PeriodCompletedNCT00695071Phase 1
- Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male SubjectsCompletedNCT00694993Phase 1
- Single Dose Escalation Study FTIM in Order to Assess Safety and Tolerability of GSK610677CompletedNCT00694902Phase 1
- Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult FemalesCompletedNCT00693966Phase 2
- Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult FemalesCompletedNCT00693615Phase 2
- Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy WomenCompletedNCT00689741Phase 2
- Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of EltrombopagCompletedNCT00688272Phase 1
- Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR)CompletedNCT00688207Phase 1
- Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or LymphomaCompletedNCT00687622Phase 1
- Study to Evaluate SC Route of Administration of Ofatumumab in RA PatientsCompletedNCT00686868Phase 1
- A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid TumorsWithdrawnNCT00682279Phase 1
- Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK580416TerminatedNCT00680485Phase 1
- The Effectiveness of Varicella Vaccination in Children in GermanyCompletedNCT00679796
- An Observational Study For AmbrisentanCompletedNCT00679224
- A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid TumorsCompletedNCT00678977Phase 1
- A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II DiabetesCompletedNCT00675857Phase 2
- GW823296 Repeat Dose Study In Healthy Male And Female SubjectsCompletedNCT00675116Phase 1
- Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's DiseaseCompletedNCT00675090Phase 1
- Single-Blind, Placebo-Controlled, Randomized Study Testing Single Ascending Doses Of GSK369796 In Healthy SubjectsCompletedNCT00675064Phase 1
- Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid ArthritisCompletedNCT00674635Phase 2
- A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or HydrochlorothiazideCompletedNCT00671424Phase 1
- A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects.CompletedNCT00671216Phase 1
- Study to Investigate AKT Inhibitor GSK690693 in Subjects With Relapsed or Refractory Hematologic MalignanciesWithdrawnNCT00666081Phase 1
- FTIH Study With GSK958108CompletedNCT00664365Phase 1
- Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00662805
- Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye DropsCompletedNCT00659555Phase 1
- A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744CompletedNCT00659191Phase 1
- Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian CancerCompletedNCT00659178Phase 1
- Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)CompletedNCT00657007Phase 1
- A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3CompletedNCT00656006Phase 2
- Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in InfantsCompletedNCT00655187
- Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in PanamaCompletedNCT00653198
- To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal FemalesCompletedNCT00651534Phase 1
- A Single Dose Bioequivalence Study OfTwo Formulations Of Nicotine LozengesCompletedNCT00651352Phase 1
- GSK1247303 First Time in Human StudyTerminatedNCT00651079Phase 1
- Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast CancerCompletedNCT00650910Phase 1
- A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary InsomniaCompletedNCT00650871Phase 2
- Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes SubjectsCompletedNCT00648284
- LENS - Long-term Eltrombopag Observational StudyCompletedNCT00643929
- Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency VirusCompletedNCT00643643Phase 2
- A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00642148Phase 2
- A Study in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic AssaysCompletedNCT00637351
- Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency VirusCompletedNCT00634959Phase 2
- GSK1349572 Repeat Dose Escalation and Relative Bioavailability StudyCompletedNCT00631592Phase 1
- AED/Statin Interaction StudyCompletedNCT00627575Phase 1
- A Study to Assess the Safety of Repeated Doses of GSK189075 and WELLBUTRIN SR in Healthy Male SubjectsCompletedNCT00625859Phase 1
- Comparing Two Respiratory Drugs in Combination and Separately From a Novel Inhaler Device in Healthy Japanese SubjectsCompletedNCT00625196Phase 1
- Phase I Study of SB-480848(Darapladib) -Repeat Dose Study in Healthy Japanese Male Subjects-CompletedNCT00622830Phase 1
- Anti-MAG First Administration to HumanCompletedNCT00622609Phase 1
- Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment ContinuationCompletedNCT00621894Phase 2
- A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid TumorsCompletedNCT00619424Phase 1
- Repeat Dose Study in Male Healthy Volunteer SmokersCompletedNCT00615576Phase 1
- Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast CancerWithdrawnNCT00615524Phase 2
- Effect of GSK376501 on CYP450 Activity in Healthy Adult SubjectsCompletedNCT00615212Phase 1
- A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)CompletedNCT00612820Phase 2
- A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic RhinitisCompletedNCT00612118Phase 2
- A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.CompletedNCT00609596Phase 1
- A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy VolunteersCompletedNCT00608699Phase 1
- First-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050CompletedNCT00607906Phase 1
- A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary InsomniaCompletedNCT00606697Phase 2
- Investigation Of a New Oral Anti-Histamine in Healthy Male SubjectsCompletedNCT00605852Phase 1
- SD Cystic Fibrosis StudyCompletedNCT00605761Phase 1
- A Drug Interaction Study Between Simvastatin and GSK376501CompletedNCT00605449Phase 1
- Bioequivalence and Food Effect of 250mg of Lamotrigine XRCompletedNCT00605371Phase 1